{"name":"Alembic Pharmaceuticals Ltd.","slug":"alembic-pharmaceuticals-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Lamotrigine ER tablet 50mg","genericName":"Lamotrigine ER tablet 50mg","slug":"lamotrigine-er-tablet-50mg","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"Lamotrigine ER tablet 50mg","genericName":"Lamotrigine ER tablet 50mg","slug":"lamotrigine-er-tablet-50mg","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxOME9OZ192Mmp1U0ZRelZvWXo0a2FvMmJhYzhUQlNJSjBDWGZucDlkTV9jdTR6VHk2RTV0enlmb2E1eUZVX3l3UC1vdkZGck1mUHo5a19Ca2tNNlhIcUt3V3Z6bmNCVlFadmEwMXhONklTcmNYYzY5XzhsVUJUd1licks5TUpTRERJNjgySjRVdzVMT0N5b2V6OFNlRElxRFJt0gGmAUFVX3lxTE5GdDgwSXVsVTIyWHdEbWFEYU4xVFM4anpGSFhGUnFuMk5qSnlPVUhiZUFWcDFUeVVhTnE2cVVhTUNrTnhGYVhuNUt0eU9nVVUzekJXS1liQ2lzWnJra1MzQjVTMlRMdjhnVXV2ZC03Wm9OU0hWMlp0MzItcTBLUGxYQV9HN29YbHM4ZjBlSHB3cy1vM1kwQXYxUTRENE9PU25BR3BSdUE?oc=5","date":"2026-04-07","type":"regulatory","source":"Rediff MoneyWiz","summary":"Alembic Pharma Gets USFDA Nod for Dapagliflozin - Rediff MoneyWiz","headline":"Alembic Pharma Gets USFDA Nod for Dapagliflozin","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-04-07","type":"regulatory","source":"CNBC TV18","summary":"Alembic Pharma gains 4% on USFDA nod for key diabetes drug - CNBC TV18","headline":"Alembic Pharma gains 4% on USFDA nod for key diabetes drug - CNBC TV18","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-04-07","type":"regulatory","source":"Business Standard","summary":"Alembic Pharma receives USFDA approval for generic dapagliflozin tablets - Business Standard","headline":"Alembic Pharma receives USFDA approval for generic dapagliflozin tablets","sentiment":"positive"},{"url":"https://news.google.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?oc=5","date":"2026-04-02","type":"earnings","source":"Indian Pharma Post","summary":"Alembic Pharmaceuticals partners with Enthral.ai for learning and training management of its 9000+ learners - Indian Pharma Post","headline":"Alembic Pharmaceuticals partners with Enthral.ai for learning and training management of its 9000+ learners","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxOblV6dnVsdmFQOTlRZl9zU05ZYjZ5LTE2ZEFtMFUtc0VDVXBWUEtjMWFkWFN2MmlQOTFfT2pEVmJ4azJZQk5FLW1vbXdBOTJaQTVxTl92M0xuRnkyV05acjVTdU10VVFUVFpWYU8tM1Z0YUlwY2JBRzhWaExCMVM2OWZLWElCeUtLU21uVkkzdENlUQ?oc=5","date":"2026-03-30","type":"regulatory","source":"Microbioz India","summary":"Alembic Pharma Gets USFDA Approval for Paroxetine ER Tablets - Microbioz India","headline":"Alembic Pharma Gets USFDA Approval for Paroxetine ER Tablets","sentiment":"positive"},{"url":"https://news.google.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?oc=5","date":"2026-02-20","type":"regulatory","source":"Medical Dialogues","summary":"Alembic Pharma Gets 2 USFDA Observations for Karakhadi Injectable Facility - Medical Dialogues","headline":"Alembic Pharma Gets 2 USFDA Observations for Karakhadi Injectable Facility","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-AFBVV95cUxNNnVrYklULWk4YlVOSm9XbVVfV3BPdDdadDdTOFdLZHB5TUxWVFZ3dENXUXF4dDJ2NnY2VlU1d1JablQxOGRvMHdORFY4Ti05aXpuRW55d1VIUHdfLWpDU0ZYcVhMM0lLWmFWZjdpQk9pMmtuTjNuZXNwYjM3bDNmWmc2MGhuMGNmQnliVHZGVzY3YjBOc2c3d0F5VzlrODdZUi1CZW1RdXF1eXhuRjBrcW85MXM2bENYcFJGM2c1RjVDN0pfVjQ4UTI4dHozR2FYamxXem9DQm92UzBDZmZJeDNCWGpfamlJTHRIU3NHWXY5d2ZsSmVoV9IB_gFBVV95cUxNU0RvNzZSSHFJRXlWWU1xM0RJNU1KbW5oZUM4dExYQlYtVTZYVkFRbllfUzhTTkhFTjBndzhEZEYzWVdvTlBxeVo4cjFubkFqNWc1WU51RmlXak1zd1QzQmw3TXVyZllSU3ZDMmJaTGE1bEY4WmJSdEZ2UTBVd2c0SnFoOGxLdjlXZnlWN1FTMFdoUW5HYTZyNm5sTkdrcFpOT0hQV2ZTQjZHMlVkTmZkbHRWdGpzLVZvOEw1UVM5TUdzQU5tNzhFdFVsRFg2ZUxVRFFSQmpib1BvSGtrSVU0MmdJemthcUE5RG1WclZrTjBMdjAycmVxZkNHNTFJZw?oc=5","date":"2026-02-08","type":"earnings","source":"simplywall.st","summary":"Alembic Pharmaceuticals Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now - simplywall.st","headline":"Alembic Pharmaceuticals Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now","sentiment":"negative"},{"url":"https://news.google.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?oc=5","date":"2026-02-06","type":"earnings","source":"ET Pharma","summary":"Alembic Pharma net profit falls 4% to ₹133 crore in Q3 FY26 - ET Pharma","headline":"Alembic Pharma net profit falls 4% to ₹133 crore in Q3 FY26","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMi2gFBVV95cUxPbHkzdjQwaV9OT05UUXdfVEd5U2pXeUJFOXUxQmNDeGY5VTlIQmhHdHM0ZERzLVgxWDVVVmFsbDZCZzRVQThXdWpodHp6b2ZhTl9HMS04QVhvbTVEa0JqQVNyV2ZneEVZLW9JWDdUQ3dsRFRKbU5kY29XOURMUlhPRVMwOTd4RlRZU1liZVZGQkFNd2VCbG9hWFZnYWhNNURmREQ3dGxUVjJndVNPNXZYWUhRaHdVOTJ2cnNXaVVwMk1SbHBUUnowQXR4cllfNHFNeDZycGU5Vl9VQQ?oc=5","date":"2026-02-05","type":"earnings","source":"Reuters","summary":"Drugmaker Alembic Pharma posts earnings dip on Indian labour code changes - Reuters","headline":"Drugmaker Alembic Pharma posts earnings dip on Indian labour code changes","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxONUljQ25XYmFXRVJ2QnlOOGZucDBXdWMta0ZtdzB6dHJ0YmV4MkdNc293dzM1Y09RY0N6ZDBFNFh1cHlseUxFRkhhaTdUQ1g2QTFQR1JYQ2hvNlM1ZVRKN1lId2tPMmo4S2p3RkxtLVJGckpXZXBaQ3d6YzNyMVptMVBqXzlROWRBWUtfOVhyRWg0dw?oc=5","date":"2026-02-05","type":"earnings","source":"Yahoo Finance Singapore","summary":"Drugmaker Alembic Pharma posts earnings dip on Indian labour code changes - Yahoo Finance Singapore","headline":"Drugmaker Alembic Pharma posts earnings dip on Indian labour code changes","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2AFBVV95cUxOS0VEbk4tOU9iOElzOTJDM01SQ3FQNzRyeTBUNlJUUVV3N1hvdnQ4UlJURGtydGhNUEdxcmRfYUJYSDFMMTlrbEdoZ0pOLWhOSEFiWHA4WDZGd1dYdFBHOVVQaUJyYTBwZ1ZVZ2Z2S3RnM0V4TVhncVh0VEU5Yk9WOXNNeTc3Z0d6bjlvZzFTNGlxcTZDUTFGVFBvbEJJTXNyVWYzX081WFFwMXNRTjhLU2xqN1RlRHl5VjRzRkp1Y2RiTjQzc3ZPUXUyaVpTeDZaU3J5SF81Ny0?oc=5","date":"2025-12-12","type":"regulatory","source":"Eyes On Eyecare","summary":"FDA approves Alembic Pharma's loteprednol etabonate and tobramycin ophthalmic suspension - Eyes On Eyecare","headline":"FDA approves Alembic Pharma's loteprednol etabonate and tobramycin ophthalmic suspension","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi3AFBVV95cUxNRnBnNFlKWWtBUjFCOGZqTXlzNVg4TGwwU2Y4YzlrbGNwbW93a3N2SnhZVzFQcjl2MUZhOTNQSTFudzJOVllNS3QwNC1GWXlIbjdiajRVdVNVeVBTbVRpcnc1ZlFkZ2FJVTN1a3RESUN3SHFGWUpBd0N6UmlDMDVHdXY5UVFGM1hTOFctWXQyYlViejQtWm1McTBLNEs4RUFDQzdBSHdSNXFVLWhseVd3MlVKQTEtbmx2a09oaXBRYWNGekMtLTZ1WkxSS2xRVGdFVkZTSEtrRDNyZjVi?oc=5","date":"2025-11-04","type":"regulatory","source":"Reuters","summary":"India's Alembic Pharma posts quarterly profit jump on strong generics demand - Reuters","headline":"India's Alembic Pharma posts quarterly profit jump on strong generics demand","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}